Autonomous exoskeleton reduces metabolic cost of human walking
© Mooney et al.; licensee BioMed Central Ltd. 2014
Received: 10 August 2014
Accepted: 15 October 2014
Published: 3 November 2014
Passive exoskeletons that assist with human locomotion are often lightweight and compact, but are unable to provide net mechanical power to the exoskeletal wearer. In contrast, powered exoskeletons often provide biologically appropriate levels of mechanical power, but the size and mass of their actuator/power source designs often lead to heavy and unwieldy devices. In this study, we extend the design and evaluation of a lightweight and powerful autonomous exoskeleton evaluated for loaded walking in (J Neuroeng Rehab 11:80, 2014) to the case of unloaded walking conditions.
The metabolic energy consumption of seven study participants (85 ± 12 kg body mass) was measured while walking on a level treadmill at 1.4 m/s. Testing conditions included not wearing the exoskeleton and wearing the exoskeleton, in both powered and unpowered modes. When averaged across the gait cycle, the autonomous exoskeleton applied a mean positive mechanical power of 26 ± 1 W (13 W per ankle) with 2.12 kg of added exoskeletal foot-shank mass (1.06 kg per leg). Use of the leg exoskeleton significantly reduced the metabolic cost of walking by 35 ± 13 W, which was an improvement of 10 ± 3% (p = 0.023) relative to the control condition of not wearing the exoskeleton.
The results of this study highlight the advantages of developing lightweight and powerful exoskeletons that can comfortably assist the body during walking.
For over a century, researchers have designed stand-alone, or autonomous, exoskeletal mechanisms with the hope of amplifying human ambulatory performance. Previous exoskeletal research has resulted in many interesting designs and much has been learned regarding human-machine interaction [1–5]. However, the development of an effective autonomous exoskeleton remained a challenge until very recently. Our recent publication described an autonomous ankle exoskeleton that reduced the metabolic burden to walk by 8% while carrying load, when compared to not wearing the device . This previous investigation provided important insight into the feasibility of autonomous exoskeletons for loaded walking, but not the more common case of unloaded walking.
In the present study, we refine the previously published exoskeletal design described in  and further evaluate its impact on the metabolic consumption for unloaded, level ground walking. In our previous study  we presented the Augmentation Factor (AF), a metric that predicts the metabolic impact of a device based on exoskeletal mass and power characteristics. Based on the AF, we hypothesized that the revised exoskeletal design would significantly reduce the metabolic energy consumed by a human wearer for normal, unloaded walking. We evaluated this hypothesis by measuring the metabolic energy consumption of seven study participants walking on a level treadmill at 1.4 m/s. Testing conditions included participants not wearing the exoskeleton and wearing the exoskeleton, both for powered on and powered off exoskeletal modes.
Exoskeleton component mass distribution
Foot & Shank
The onboard controllers and gyroscopes implemented an adaptive timing strategy to consistently generate positive power during late stance powered plantar flexion and zero torque during swing. The integrated gyroscope was sampled at 250 Hz and filtered with a 2nd order, 6 Hz low pass Butterworth filter. Subsequently, the signal was used to estimate the shank’s angular velocity in the sagittal plane for the detection of walking gait phases. Specifically, heel contact after a swing phase was estimated to occur when a positive shank velocity (leg protraction) was continuously detected for 220 ms or longer, followed by an angular velocity zero-crossing resulting in the velocity first becoming negative (the initiation of leg retraction). At heel strike, the adaptive timer started (400–500 ms) and the exoskeleton applied a slight plantar flexion torque to maintain tension in the cord. The end of the timer signaled the beginning of stance phase power assistance. Power assistance was achieved by applying a parabolic voltage profile to the motor over 150 ms. Subsequent to power assistance, the controller automatically entered swing phase. At this time, the controller quickly released the cord over 125 ms to provide slack so as not to impede the user. Finally, the controller entered an idle state after providing slack until the next ipsilateral heel strike was detected.
Timing and power magnitude were adjusted to align with reference biological power profiles . The mechanical power applied by the exoskeleton was estimated with a linear motor model and an actuator efficiency characterization . Using the period of the previous step, the location and magnitude of the peak power were estimated. The adaptive timer duration was incrementally adjusted such that the peak power aligned with 53% gait cycle . Similarly, the amplitude of the mechanical power profile was continuously adjusted to maintain a normalized peak power of 2.3 W/kg, 70% of the peak ankle power typically reported for normal walking . This mechanical power level was chosen to prevent the thermal overload of the motors while testing with participants that had greater mass.
The metabolic effect of the autonomous powered exoskeleton on level ground walking was experimentally determined using seven study participants (6 male; 1 female; 85 ± 12 kg body mass; 180 ± 9 cm stature; 26 ± 5 years old; mean ± standard deviation). Participants walked on a treadmill at 1.4 m/s, approximately equal to the average adult walking speed . All participants were healthy and exhibited no gait abnormalities. This study was approved by the MIT Committee on the Use of Humans as Experimental Subjects, and informed consent was obtained from experimental participants. A portable pulmonary gas exchange measurement instrument (model: K4b2, COSMED, Rome, IT) was worn by the participants during four walking trials and two standing trials. The tests began with the participants standing for 6 minutes, in order to obtain a resting metabolic rate. Then, each participant walked for 10 minutes without the exoskeleton, 20 minutes while wearing the exoskeleton in a powered on statea, 20 minutes with the exoskeleton in a powered off state, and once again 10 minutes without the exoskeleton.
Metabolic rate was calculated from oxygen consumption and carbon dioxide production rates measured by the portable pulmonary gas exchange measurement unit. The average rates of the last five minutes of each trial were converted into metabolic power using the equation developed by Brockway et al. . The metabolic rate of standing was subtracted from the gross metabolic rates of walking in order to obtain the net metabolic costs of walking. The net metabolic rates measured from the two control trials were averaged and compared to the net metabolic rates of the exoskeleton trials.
In this study, an autonomous ankle exoskeleton was shown to reduce the metabolic cost of level walking. Compared to our previous design , the present exoskeleton includes a modified transmission ratio and shorter struts that resulted in an exoskeletal mass reduction of 363 g. The metabolic results align with the device’s AF, strengthening this metric as a tool for researchers. In the development of leg exoskeletons designed to reduce walking metabolism, we feel minimizing exoskeletal power dissipation and added limb mass, while providing substantial positive power, are of paramount importance.
aOne experimental participant walked for only 12 minutes (instead of 20 minutes) with the exoskeleton powered on due to a device malfunction.
This work was supported by the National Science Foundation Graduate Research Fellowship award number 1122374.
- Yagn N: Apparatus for facilitating walking, running, and jumping. 1890.Google Scholar
- Zoss A, Kazerooni H, Chu A: Biomechanical design of the Berkeley lower extremity exoskeleton (BLEEX). IEEE/ASME Trans Mechatronics 2006, 11: 128-138.View ArticleGoogle Scholar
- Malcolm P, Derave W, Galle S, De Clercq D: A simple exoskeleton that assists plantarflexion can reduce the metabolic cost of human walking. PLoS One 2013, 8: e56137. 10.1371/journal.pone.0056137View ArticlePubMedPubMed CentralGoogle Scholar
- Sawicki GS, Ferris DP: Mechanics and energetics of level walking with powered ankle exoskeletons. J Exp Biol 2008,211(Pt 9):1402-1413.View ArticlePubMedGoogle Scholar
- Ferris DP, Czerniecki JM, Hannaford B: An ankle-foot orthosis powered by artificial pneumatic muscles. J Appl Biomech 2005, 21: 189-197.PubMedPubMed CentralGoogle Scholar
- Mooney LM, Rouse EJ, Herr HM: Autonomous exoskeleton reduces metabolic cost of human walking during load carriage. J Neuroeng Rehabil 2014, 11: 80. 10.1186/1743-0003-11-80View ArticlePubMedPubMed CentralGoogle Scholar
- Winter D: Biomechanical motor patterns in normal walking. J Mot Behav 1983, 15: 303-330.View ArticleGoogle Scholar
- Bohannon RW: Comfortable and maximum walking speed of adults aged 20–79 years: reference values and determinants. Age Ageing 1997, 26: 15-19.View ArticlePubMedGoogle Scholar
- Brockway JM: Derivation of formulae used to calculate energy expenditure in man. Hum Nutr Clin Nutr 1987, 41: 463-471.PubMedGoogle Scholar
- Sawicki GS, Ferris DP: Powered ankle exoskeletons reveal the metabolic cost of plantar flexor mechanical work during walking with longer steps at constant step frequency. J Exp Biol 2009,212(Pt 1):21-31.View ArticlePubMedGoogle Scholar
- Walsh CJ, Endo K, Herr H: A quasi-passive leg exoskeleton for load-carrying augmentation. Int J Humanoid Robot 2007, 04: 487-506. 10.1142/S0219843607001126View ArticleGoogle Scholar
- Van Dijk W, van der Kooij H, Hekman E: A passive exoskeleton with artificial tendons. Proc IEEE Int Conf Rehabil Robot 2011.Google Scholar
- Donelan JM, Li Q, Naing V, Hoffer JA, Weber DJ, Kuo AD: Biomechanical energy harvesting: generating electricity during walking with minimal user effort. Science 2008, 319: 807-810. 10.1126/science.1149860View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.